Identification of LILRB4 as a regulator of M2c macrophages and a potential immunotherapeutic target in ovarian cancer
IntroductionOvarian cancer (OC) is the most lethal gynecological malignancy. A deeper insight into tumor microenvironment (TME) interactions is essential for developing novel therapeutic approaches. leukocyte immunoglobulin-like receptor B4 (LILRB4) is…